| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.28B | -6.0% |
| Cost of Revenue | $7.92B | -5.0% |
| Gross Profit | $2.36B | -9.5% |
| R&D Expense | $130.0M | -11.0% |
| SG&A Expense | $1.03B | -4.2% |
| Operating Income | -$697.0M | -141.3% |
| Interest Expense | $676.0M | -6.1% |
| Pre-tax Income | -$996.0M | -184.2% |
| Income Tax | $510.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.12B | -9.8% |
| Inventory | $2.28B | -3.1% |
| Current Assets | $5.14B | -17.3% |
| Total Assets | $22.86B | -14.1% |
| Current Liabilities | $3.85B | -5.4% |
| Long-term Debt | $12.53B | -6.5% |
| Stockholders' Equity | $5.17B | -27.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $966.0M | -49.1% |
| Capital Expenditures | $435.0M | -23.4% |
| Investing Cash Flow | -$470.0M | -250.7% |
| Financing Cash Flow | -$1.31B | +9.8% |
| Free Cash Flow | $531.0M | -60.1% |
| +164.6% |
| Net Income | -$1.52B | -177.7% |
| EPS (Basic) | -$13.93 | -177.3% |
| EPS (Diluted) | -$13.93 | -177.7% |